Patent 7612053 was granted and assigned to Paratek Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.
7-substituted fused ring tetracycline compounds, methods of treating tetracycline responsive states, and pharmaceutical compositions containing the 7-substituted fused ring tetracycline compounds are described.